Skip to main content

Advertisement

SpringerLink
Log in

Future drugs for migraine

  • IM - Commentary
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Farinelli I, DeFilippis S, Coloprisco G et al (2009) Future drugs for migraine. Int Emerg Med. doi:10.1007/s11739-009-0273-0

  2. Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and need of preventive therapy. Neurology 68:343–349

    Article  PubMed  CAS  Google Scholar 

  3. Tfelt-Hansen P, Le H (2009) Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review. J Headache Pain 10:137–143

    Article  PubMed  CAS  Google Scholar 

  4. Gupta R, Ahmed T, Banerjee B, Bhatia M (2009) Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension-type headache subjects during inter-ictal period. J Headache Pain 10:161–166

    Article  PubMed  CAS  Google Scholar 

  5. Ho TW, Ferrari MD, Dodick DW et al (2008) Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 372:2115–2123

    Article  PubMed  CAS  Google Scholar 

  6. Szallasi A, Cruz F, Geppetti P (2006) TRPV1: a therapeutic target for novel analgesic drugs? Trends Mol Med 12:545–554

    Article  PubMed  CAS  Google Scholar 

  7. Chizh BA, O’Donnell MB, Napolitano A et al (2007) The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 132:132–141

    Article  PubMed  CAS  Google Scholar 

  8. Maubach KA, Davis RJ, Clark DE et al (2009) G BGC20–1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache. Br J Pharmacol 156:316–327

    Article  PubMed  CAS  Google Scholar 

  9. Steiner TJ, Paemeleire K, Jensen R et al (2007) European principles of management of common headache disorders in primary care. J Headache Pain 8:S3–S47

    Article  PubMed  Google Scholar 

  10. Filatova E, Latysheva N, Kurenkov A (2008) Evidence of persistent central sensitization in chronic headaches: a multi-method study. J Headache Pain 9:295–300

    Article  PubMed  Google Scholar 

  11. Allena M, Katsarava Z, Nappi G, The COMOESTAS consortium (2009) From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin-American countries. J Headache Pain 10:71–76

    Article  PubMed  Google Scholar 

  12. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 289:65–69

    Article  PubMed  CAS  Google Scholar 

  13. Tvedskov JF, Iversen HK, Olesen J (2004) A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine. Cephalalgia 24:875–882

    Article  PubMed  CAS  Google Scholar 

  14. Weiss B, Alt A, Ogden AM et al (2006) Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo. J Pharmacol Exp Ther 318:772–781

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

The author declares that he has no conflict of interest related to the publication of this manuscript.

Author information

Authors and Affiliations

  1. Headache Centre, University of Modena and Reggio Emilia, via del Pozzo, 71, 41100, Modena, Italy

    Luigi Alberto Pini

Authors
  1. Luigi Alberto Pini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luigi Alberto Pini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pini, L.A. Future drugs for migraine. Intern Emerg Med 4, 361–362 (2009). https://doi.org/10.1007/s11739-009-0299-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-009-0299-3

Keywords

Search

Navigation